Search results
Results from the WOW.Com Content Network
The group found that people taking the GLP-1 medications had a lower risk of a number of health conditions, including Alzheimer’s disease and dementia, addiction, seizures, blood-clotting ...
Hormone-related health conditions, like polycystic ovary syndrome (PCOS) and hypothyroidism, as well as life seasons like menopause, can lead to hormonal changes that make losing weight more ...
Tirzepatide Weight Loss Injections. Tirzepatide is the active ingredient in Mounjaro® and Zepbound®. Like Ozempic, Mounjaro is FDA-approved as a diabetes drug. It can help folks with type 2 ...
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of the human body , weight regulation, by: reducing appetite and consequently energy intake , increasing energy expenditure , redirecting nutrients from adipose to lean ...
A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist. Taking This Weight-Loss Medication Could ...
Moon face is often associated with Cushing's syndrome [5] [6] or steroid treatment (especially corticosteroids), which has led to it being known as Cushingoid facies. [7]Moon face is a type of corticosteroid-induced lipodystrophy along with "buffalo hump", which in one study occurred in 47% of the 820 patients.
GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now.
One study found a weight loss of between 14% and 25% (depending on the type of procedure performed) at 10 years, and a 29% reduction in all cause mortality when compared to standard weight loss measures. [214] Complications occur in about 17% of cases and reoperation is needed in 7% of cases. [212]